## Abstract Infection of periprosthetic sites of total joint replacements has been widely reported. Although, by most accounts, the incidence of such events is low, the problem can prove to be expensive to remedy. In the case of cemented arthroplasties, a common management modality is the use of an
Antibiotic bone cement for the treatment of pseudomonas aeruginosa in joint arthroplasty: Comparison of tobramycin and gentamicin-loaded cements
✍ Scribed by Scott, Christopher P. ;Higham, Paul A.
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 129 KB
- Volume
- 64B
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
One hundred clinical isolates of Pseudomonas aeruginosa were collected from 22 medical centers throughout Europe and were challenged with two aminoglycoside‐loaded bone cements, employing a modified in vitro Kirby–Bauer susceptibility model. The results of this study show that Simplex® P with tobramycin exhibits antibacterial activity against 98% of the strains tested, compared to 93% for Palacos with gentamicin. Additionally, for strains that were susceptible to the antibiotic bone cement formulations, the average zone of inhibition produced around the tobramycin‐loaded cement disks was approximately 25% greater than that seen around the gentamicin‐loaded cement disks. This difference was statistically significant (p ≪ 0.01). Tobramycin‐loaded bone cement is therefore the preferred formulation when addressing Pseudomonas aeruginosa in septic joint arthroplasty. © 2002 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 64B: 94–98, 2003
📜 SIMILAR VOLUMES